NCT05987761

Brief Summary

The purpose of this study is to identify improvement in behavioral and social function and changes in the brain following Pivotal Response Treatment (PRT) for Adolescents in highly verbal adolescents with autism spectrum disorder (ASD).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for not_applicable

Timeline
4mo left

Started Sep 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress89%
Sep 2023Aug 2026

First Submitted

Initial submission to the registry

March 10, 2023

Completed
5 months until next milestone

First Posted

Study publicly available on registry

August 14, 2023

Completed
18 days until next milestone

Study Start

First participant enrolled

September 1, 2023

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2026

Last Updated

March 28, 2024

Status Verified

March 1, 2024

Enrollment Period

3 years

First QC Date

March 10, 2023

Last Update Submit

March 26, 2024

Conditions

Keywords

AutismAutism Spectrum DisorderPRTPivotal Response TreatmentAutism interventionSocial skillsAdolescents

Outcome Measures

Primary Outcomes (2)

  • (Target) Change from baseline (Pre-training) in brain connectivity between superior temporal sulcus (STS) and the nucleus accumbens (NAc)

    Target engagement consists of brain connectivity between voice selective superior temporal sulcus (STS) and the nucleus accumbens (NAc) of the mesolimbic reward system. For the PRT (i.e., intervention) group, brain connectivity will be measured using the generalized psychophysiological interaction (gPPI) model, a common measure of task-based brain connectivity using fMRI data. gPPI betas from individual subject contrast maps will be computed using the STS as a seed region and the NAc as the connectivity target region. Effect size will be computed using Cohen's d for a paired t-test comparing Post-Training and Pre-Training pSTS-NAc connectivity values (i.e., contrast betas): d = t/(sqrt(n) where t is the paired t-test and n the group size.

    Pre-treatment baseline, and between 11 to 13 weeks post-baseline

  • Change from baseline (Pre-training) in structured laboratory observations (SLO) of child-assessor interactions

    The Structured Laboratory Observations (SLO) of child-assessor interactions is a common behavioral measure of each participant's social communicative interactions assessed in a laboratory setting. The metric used to characterize the SLO is an overall percentage of appropriate social responsiveness. Change in baseline SLO will be computed by subtracting Post- from Pre-training percentage of appropriate social responsiveness for each participant in the PRT group.

    Pre-treatment baseline, and between 11 to 13 weeks post-baseline

Secondary Outcomes (6)

  • Change in the Social Communication subscale of the Brief Observation of Social Communication Change (BOSCC)

    Pre-treatment baseline, and between 11 to 13 weeks post-baseline

  • (Secondary target) Change in brain connectivity between superior temporal sulcus (STS) and temporoparietal junction (TPJ)

    Pre-treatment baseline, and between 11 to 13 weeks post-baseline

  • Association between change in target engagement and change in clinical benefit (STS and NAc)

    Pre-treatment baseline, and between 11 to 13 weeks post-baseline

  • Association between change in target engagement and change in clinical benefit (STS and TPJ)

    Pre-treatment baseline, and between 11 to 13 weeks post-baseline

  • Group differences in the association between change in target engagement and clinical benefit (STS and NAc)

    Pre-treatment baseline, and between 11 to 13 weeks post-baseline

  • +1 more secondary outcomes

Study Arms (2)

PRT Treatment Group

EXPERIMENTAL

After study participants have completed screenings to meet our inclusion criteria, participants will take part in the pre-intervention MRI brain scan and behavioral assessments and will then be assigned randomly to one of two arms of intervention for 9 weeks. Participants in the PRT Treatment Group will complete an 9-week intervention, PRT for Adolescents, to improve the adolescent's social skills. Following the completion of the 9-week intervention, participants will be asked to complete a second MRI brain imaging session, followed by post-measure appointments in order to assess immediate effects of the intervention.

Behavioral: PRT for Adolescents

Delayed Treatment Group

EXPERIMENTAL

After study participants have completed screenings to meet our inclusion criteria, participants will take part in the pre-intervention MRI brain scan and behavioral assessments and will then be assigned randomly to one of two arms of intervention for 9 weeks. After 9-weeks without any intervention, participants in the Delayed Treatment Group will be asked to complete a second MRI brain imaging session, followed by post-measure appointments, and will then receive the PRT intervention at the end of the study.

Behavioral: PRT for Adolescents

Interventions

Clinician-led 70-minute PRT sessions targeting social skills once per week at Stanford.

Delayed Treatment GroupPRT Treatment Group

Eligibility Criteria

Age11 Years - 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Clinical Diagnosis of Autism Spectrum Disorder, higher functioning/low support needs
  • Intelligence Quotient (IQ): Participants with a Full Scale IQ \> 80 on the Wechsler Abbreviated Scale of Intelligence (WASI-II)
  • Right-handed
  • No metal in their body/unremovable metal on their body (i.e., braces)
  • First language is English
  • Must live in the San Francisco Bay Area
  • Able and willing to receive intervention weekly for 9 weeks
  • Adolescent is interested in improving their social skills
  • MRI Compatibility: No major contraindication for MRI.
  • Diagnosis of ASD using ADOS-2 and ADI-R.
  • No evidence of a genetic, metabolic, or infectious etiology for their autism.
  • Primary diagnosis of ASD
  • No evidence of significant difficulty during pregnancy, labor, delivery, or immediate neonatal period.
  • Stable treatment (e.g., ABA), speech therapy, school placement, psychotropic medication(s) or biomedical intervention(s) for at least 1 month prior to baseline measurements with no anticipated changes during study participation.
  • Score of at least 50% or below on at least 4 out of the 9 social target areas in the SLO (administered during pre-measures)
  • +1 more criteria

You may not qualify if:

  • History of claustrophobia, previous head injury, serious neurological or medical illness, birth weight less than 4 lb. and/or gestational age \< 34 weeks
  • Left-handed
  • Braces or any metal in their body

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford Research Park

Palo Alto, California, 94304, United States

RECRUITING

MeSH Terms

Conditions

Autistic DisorderDevelopmental DisabilitiesChild BehaviorSocial BehaviorAutism Spectrum DisorderSocial Skills

Interventions

Hypoxanthine Phosphoribosyltransferase

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental DisordersBehavior

Intervention Hierarchy (Ancestors)

PentosyltransferasesGlycosyltransferasesTransferasesEnzymesEnzymes and Coenzymes

Study Officials

  • Dani A Abrams, Ph.D.

    Stanford University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Assistant Professor

Study Record Dates

First Submitted

March 10, 2023

First Posted

August 14, 2023

Study Start

September 1, 2023

Primary Completion (Estimated)

August 31, 2026

Study Completion (Estimated)

August 31, 2026

Last Updated

March 28, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations